Fournier L, Phadke R, Salgado M, Brack A, Nocon J, Bolshakova S
iScience. 2024; 27(9):110800.
PMID: 39310747
PMC: 11416532.
DOI: 10.1016/j.isci.2024.110800.
Fournier L, Phadke R, Salgado M, Brack A, Nocon J, Bolshakova S
bioRxiv. 2024; .
PMID: 38328248
PMC: 10849664.
DOI: 10.1101/2024.01.27.575409.
Nestoros J, Vallianatou N
Front Hum Neurosci. 2022; 16:923695.
PMID: 36211131
PMC: 9532604.
DOI: 10.3389/fnhum.2022.923695.
Li D, Wu Q, Han X
Front Cell Neurosci. 2022; 16:939294.
PMID: 35865112
PMC: 9294455.
DOI: 10.3389/fncel.2022.939294.
Zheng X, Wang C, Zhai N, Luo X, Liu G, Ju X
Int J Mol Sci. 2021; 22(17).
PMID: 34502550
PMC: 8431797.
DOI: 10.3390/ijms22179645.
A transcriptome-wide association study implicates specific pre- and post-synaptic abnormalities in schizophrenia.
Hall L, Medway C, Pain O, Pardinas A, Rees E, Escott-Price V
Hum Mol Genet. 2019; 29(1):159-167.
PMID: 31691811
PMC: 7416679.
DOI: 10.1093/hmg/ddz253.
Therapeutic Particularities with Depot Medications in Schizophrenia.
Sarbu C, Badescu G, Hromei A, Stania I
Curr Health Sci J. 2019; 44(3):322-325.
PMID: 30647956
PMC: 6311213.
DOI: 10.12865/CHSJ.44.03.19.
Gabrb2-knockout mice displayed schizophrenia-like and comorbid phenotypes with interneuron-astrocyte-microglia dysregulation.
Yeung R, Xiang Z, Tsang S, Li R, Ho T, Li Q
Transl Psychiatry. 2018; 8(1):128.
PMID: 30013074
PMC: 6048160.
DOI: 10.1038/s41398-018-0176-9.
Maternal immune activation alters glutamic acid decarboxylase-67 expression in the brains of adult rat offspring.
Cassella S, Hemmerle A, Lundgren K, Kyser T, Ahlbrand R, Bronson S
Schizophr Res. 2016; 171(1-3):195-9.
PMID: 26830319
PMC: 4803111.
DOI: 10.1016/j.schres.2016.01.041.
Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia.
Pocklington A, Rees E, Walters J, Han J, Kavanagh D, Chambert K
Neuron. 2015; 86(5):1203-14.
PMID: 26050040
PMC: 4460187.
DOI: 10.1016/j.neuron.2015.04.022.
Interneuron dysfunction in psychiatric disorders.
Marin O
Nat Rev Neurosci. 2012; 13(2):107-20.
PMID: 22251963
DOI: 10.1038/nrn3155.
Functional regulation of GABAA receptors in nervous system pathologies.
Hines R, Davies P, Moss S, Maguire J
Curr Opin Neurobiol. 2011; 22(3):552-8.
PMID: 22036769
PMC: 3846183.
DOI: 10.1016/j.conb.2011.10.007.
The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.
Wieronska J, Kusek M, Tokarski K, Wabno J, Froestl W, Pilc A
Br J Pharmacol. 2011; 163(5):1034-47.
PMID: 21371011
PMC: 3130949.
DOI: 10.1111/j.1476-5381.2011.01301.x.
Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons.
Ting A, Chen Y, Wen L, Yin D, Shen C, Tao Y
J Neurosci. 2011; 31(1):15-25.
PMID: 21209185
PMC: 3078582.
DOI: 10.1523/JNEUROSCI.2538-10.2011.
Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia.
Damgaard T, Plath N, Neill J, Hansen S
Psychopharmacology (Berl). 2010; 214(2):403-13.
PMID: 20957350
DOI: 10.1007/s00213-010-2039-9.
GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.
Charych E, Liu F, Moss S, Brandon N
Neuropharmacology. 2009; 57(5-6):481-95.
PMID: 19631671
PMC: 2836902.
DOI: 10.1016/j.neuropharm.2009.07.027.
GABA(B) receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implications.
Kantrowitz J, Citrome L, Javitt D
CNS Drugs. 2009; 23(8):681-91.
PMID: 19594197
PMC: 4988234.
DOI: 10.2165/00023210-200923080-00005.
Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia.
Kehrer C, Maziashvili N, Dugladze T, Gloveli T
Front Mol Neurosci. 2008; 1:6.
PMID: 18946539
PMC: 2525998.
DOI: 10.3389/neuro.02.006.2008.
Alteration in the GABAergic network of the prefrontal cortex in a potential animal model of psychosis.
Brummelte S, Neddens J, Teuchert-Noodt G
J Neural Transm (Vienna). 2007; 114(5):539-47.
PMID: 17195918
DOI: 10.1007/s00702-006-0613-4.
A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.
Yee B, Keist R, von Boehmer L, Studer R, Benke D, Hagenbuch N
Proc Natl Acad Sci U S A. 2005; 102(47):17154-9.
PMID: 16284244
PMC: 1288020.
DOI: 10.1073/pnas.0508752102.
